5-HT1 |
G1/G0-Adenylyl cyclase |
1A |
Mainly CNS |
Neuronal hyperpolarization |
G1/G0-Adenylyl cyclase |
1B |
CNS and peripheral nerves |
Inhibits neurotransmitter release |
G1/G0-Adenylyl cyclase |
1D |
Mainly CNS |
Inhibits neurotransmitter release |
G1/G0-Adenylyl cyclase |
1E |
CNS |
Inhibits adenylyl cyclase |
G1/G0-Adenylyl cyclase |
1F |
Mainly CNS |
Inhibits adenylyl cyclase |
5-HT2 |
Gq/G11-Phospholipase C |
2A |
Vascular smooth muscles, platelets, lung, CNS, GI tract |
Vasoconstriction, platelet aggregation, broncho-constriction |
Gq/G11-Phospholipase C |
2B |
Mainly peripheral |
Rat stomach muscle contraction |
Gq/G11-Phospholipase C |
2C |
CNS (concentrated in choroid plexus) |
Increases turnover of phosphoinositide |
5-HT3 |
Ligand-gated cation channel |
- |
Peripheral and central neurons |
Depolarization |
5-HT4 |
Gs-Adenylyl cyclase |
- |
GI tract, CNS, heart, urinary bladder |
Acetylcholine release in gut, tachycardia, release cAMP in CNS neurons |
5-HT5 |
G1/G0- Adenylyl cyclase |
5A |
CNS |
Unknown |
|
5B |
Absent in human |
|
5-HT6 |
Gs -Adenylyl cyclase |
- |
CNS |
Activates adenylyl cyclase |
5-HT7 |
Gs -Adenylyl cyclase |
- |
CNS |
Activates adenylyl cyclase |